Helene Karcher
5PUBLICATIONS
9CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Jan 25, 2025
Visual Acuity Outcomes and Influencing Factors in a Cohort of UK Real-World Diabetic Macular Oedema Patients During the First Two Years of Anti-VEGF Treatment.Qing Wen, Helene Karcher, David M Wright
|Nov 29, 2023
One-Year and 18-Month Outcomes in nAMD Patient Eyes Switched to Brolucizumab Alone versus to Brolucizumab Alternating with Other Anti-VEGF Agents.Joseph M Coney, Jasmyne E McCoy, Samriddhi Buxy Sinha
|Aug 16, 2023
Short-Term Treatment Outcomes of Brolucizumab in Patients with Neovascular Age-Related Macular Degeneration: A Multicentre Indian Real-World Evidence Study.Debdulal Chakraborty, Milan Thakkar, Ramesh Venkatesh
|Jun 13, 2023
Real-World Frequency and Management of Ocular Adverse Events in Eyes with Neovascular Age-Related Macular Degeneration Treated with Brolucizumab.Ryan Zubricky, Jasmyne McCoy, Richard Donkor
|Jul 08, 2018
The "RCT augmentation": a novel simulation method to add patient heterogeneity into phase III trials.Helene Karcher, Shuai Fu, Jie Meng
Pageof 1
Frequent Collaborators
2 joint publications
Joseph M Coney
1 joint publications
Debdulal Chakraborty
1 joint publications
Ramesh Venkatesh
1 joint publications
Richard Donkor
1 joint publications
Qing Wen
1 joint publications
David M Wright
1 joint publications
Recivall Salongcay
1 joint publications
Katie Curran
1 joint publications
Tunde Peto
